5-cyan0-4- (pyrrolo [2, 3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors

Details for Australian Patent Application No. 2007338754 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Young, Stephen Clinton; Knegtel, Ronald; Charrier, Jean Damien; Brenchley, Guy; Durrant, Steven; Mortimore, Michael; O'Donnell, Michael; Pinder, Joanne Louise; Rutherford, Alistair Peter; Everitt, Simon Robert Lorrie

Agent Spruson & Ferguson

Pub. Number AU-A-2007338754

PCT Pub. Number WO2008/079346

Priority 60/947,707 03.07.07 US; 60/922,291 06.04.07 US; 60/876,307 21.12.06 US; 60/989,014 19.11.07 US

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079346 Priority application(s): WO2008/079346

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338771-Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis

2007338751-Composition of and method for preparing orally disintegrating tablets contain- ing a high dose of pharmaceutically active ingredients